CN Patent

CN107427502B — 使用川地匹坦的治疗方法

Assigned to Vanda Pharmaceuticals Inc · Expires 2021-06-04 · 5y expired

What this patent protects

本申请涉及一种使用川地匹坦的治疗方法，更具体而言，涉及一种使用川地匹坦治疗瘙痒症的方法。

USPTO Abstract

本申请涉及一种使用川地匹坦的治疗方法，更具体而言，涉及一种使用川地匹坦治疗瘙痒症的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN107427502B
Jurisdiction: CN
Classification: —
Expires: 2021-06-04
Drug substance claim: No
Drug product claim: No
Assignee: Vanda Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.